Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications
Y Liu, W Ding, J Wang, X Ao, J Xue - Frontiers in oncology, 2023 - frontiersin.org
Lung cancer (LC) is a heterogeneous disease with high malignant degree, rapid growth,
and early metastasis. The clinical outcomes of LC patients are generally poor due to the …
and early metastasis. The clinical outcomes of LC patients are generally poor due to the …
microRNAs (miRNAs) in glioblastoma multiforme (GBM)—recent literature review
M Makowska, B Smolarz, H Romanowicz - International Journal of …, 2023 - mdpi.com
Glioblastoma multiforme (GBM) is the most common, malignant, poorly promising primary
brain tumor. GBM is characterized by an infiltrating growth nature, abundant vascularization …
brain tumor. GBM is characterized by an infiltrating growth nature, abundant vascularization …
Exploring ncRNA-mediated regulation of EGFR signalling in glioblastoma: From mechanisms to therapeutics
Glioblastoma (GBM) is the most prevalent and deadly primary brain tumor type, with a
discouragingly low survival rate and few effective treatments. An important function of the …
discouragingly low survival rate and few effective treatments. An important function of the …
Unraveling the impact of miR-21 on apoptosis regulation in glioblastoma
Glioblastoma is a prevalent form of carcinoma that exhibits a greater incidence rate across
diverse demographics globally. Despite extensive global efforts, GBM continues to be a …
diverse demographics globally. Despite extensive global efforts, GBM continues to be a …
Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review
MS Sadeghi, M Lotfi, N Soltani, E Farmani… - Cancer Cell …, 2023 - Springer
Carcinoma of the lung is among the most common types of cancer globally. Concerning its
histology, it is categorized as a non-small cell carcinoma (NSCLC) and a small cell cancer …
histology, it is categorized as a non-small cell carcinoma (NSCLC) and a small cell cancer …
Emerging extracellular vesicle-based carriers for glioblastoma diagnosis and therapy
Glioblastoma (GBM) treatment is still a big clinical challenge because of its highly malignant,
invasive, and lethal characteristics. After treatment with the conventional therapeutic …
invasive, and lethal characteristics. After treatment with the conventional therapeutic …
Molecular mechanisms of microRNAs in glioblastoma pathogenesis
AB Behrooz, H Latifi-Navid, A Nezhadi, M Świat… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Glioblastoma (GBM) is human's most prevalent and severe brain cancer. Epigenetic
regulators, micro (mi) RNAs, significantly impact cellular health and disease because of their …
regulators, micro (mi) RNAs, significantly impact cellular health and disease because of their …
miR-200b/MYBL2/CDK1 suppresses proliferation and induces senescence through cell cycle arrest in ovine granulosa cells
P Song, X Chen, P Zhang, Y Zhou, R Zhou - Theriogenology, 2023 - Elsevier
Normal growth of granulosa cells (GCs) is essential for follicular development. miR-200b
plays a vital role in litter size, estrous cycle, ovulation, and follicular development in sheep …
plays a vital role in litter size, estrous cycle, ovulation, and follicular development in sheep …
Exploring the role of microRNAs in glioma progression, prognosis, and therapeutic strategies
O Tluli, M Al-Maadhadi, AA Al-Khulaifi, AF Akomolafe… - Cancers, 2023 - mdpi.com
Simple Summary Despite advancements in healthcare and research, the occurrence of
gliomas, a type of brain tumor, continues to rise. Emerging evidence has proven that …
gliomas, a type of brain tumor, continues to rise. Emerging evidence has proven that …
Synergistic effect of cryptotanshinone and temozolomide treatment against human glioblastoma cells
S Zhu, J Guo, L Yu, J Liu, J Chen, J Xin, Y Zhang… - Scientific Reports, 2023 - nature.com
Glioblastoma multiforme (GBM) is a complex disease to treat owing to its profound
chemoresistance. Therefore, we evaluated the combined effect and therapeutic efficacy of …
chemoresistance. Therefore, we evaluated the combined effect and therapeutic efficacy of …